The Newsroom
Changing the future. One story at a time.
On September 18th-19th, Hyundai Hope On Wheels hosted its annual Pediatric Cancer Program in DC. Congressional leaders, Hyundai executives, dealers, Medical Advisory Committee members, pediatric cancer patients, survivors and their families, and local children’s hospitals joined together to participate in…
Ellen teamed up with Hyundai to give some amazing surprises to deserving viewers. Check it out here, then head to Hyundai's Facebook page for a chance to win a car!
The Hyundai Hope On Wheels program awarded the hospital a $250,000 grant for children's cancer research, bringing the total Hope On Wheels funding of the hospital since 2011 to $685,000. The check was presented before Hope On Wheels' signature handprint…
Hyundai Hope on Wheels, a national effort by Hyundai Motors America to raise money for childhood cancer research, is donating $500,000 to Cleveland children’s hospitals this year. The Cleveland Clinic’s Children’s Hospital and University Hospitals Rainbow Babies & Children’s Hospital…
Hyundai Hope On Wheels Celebrates the $10.25 Million Awarded to Hospitals and Institutions during September’s National Childhood Cancer Awareness Month.
Anne Cutler talks to Brian Stewart & Dr. Matthew Fletcher regarding the month-long awareness campaign and the automakers nationwide commitment to helping kids with cancer and research.
Hyundai has been a significant player in fighting pediatric cancer for years, giving a total of $72 million to the cause. On Friday, September 20, 2013 at 9:00 AM Eastern, I’ll be joined live by Hyundai USA CEO John Krafcik…
Area Hyundai dealers on Friday donated $250,000 to Children's Hospital as part of the Hyundai Hope on Wheels campaign.
Children’s Hospital has been given a $250,000 grant from Hyundai for cancer research.
Emmanuel Volanakis, M.D., assistant professor of Pediatrics and Hematology/Oncology, was awarded a $250,000 Hyundai Hope On Wheels grant last week for his ongoing research into T-cell acute lymphoblastic leukemia (ALL), an aggressive blood cancer.